查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1446492

DNA 定序市場規模、佔有率、趨勢分析報告：按產品/服務、按技術、按工作流程、按應用、按最終用途、按地區、細分市場預測，2024-2030 年

DNA Sequencing Market Size, Share & Trends Analysis Report By Product & Service, By Technology, By Workflow, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10個工作天內

價格

DNA 定序市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計2030年全球DNA定序市場規模將達到482.2億美元，2024年至2030年複合年成長率為21.65%。

人工智慧（AI）的結合將增加基因組資料在臨床實踐中的效用，並為基因組資料分析的進步創造新的領域。 2020 年 5 月，Nvidia 公司開發了新的人工智慧工具、基因測序軟體和語音辨識技術來支援 COVID-19 研究工作。因此，人工智慧將加速臨床診斷中的變異註釋和優先排序，並推動市場發展。

自人類基因計劃完成以來，DNA序列測定的成本迅速下降。十年前，對一個人的基因組進行測序的成本約為 50,000 美元，但現在最大的基因組中心的成本接近 600 美元。最近，2020 年 2 月，華大基因聲稱將基因組定序的成本降低至 100 美元。預計這將擴大其在產前檢測、癌症篩檢和研究中的應用。

顯著降低的成本和資金籌措的可用性導致多家新興企業進入市場。例如，2020年1月，美國新興企業Omniome籌集了6,000萬美元的C輪資金籌措，以加速其基因定序平台的後期產品開拓和產品上市，從而支持擴張。

DNA 定序市場報告亮點

  • 以實惠的價格提供更多的服務，以及諮詢服務、培訓課程和客戶支持，預計將在預測期內推動服務業以最快的速度成長。
  • 隨著新系統的推出，第三代技術的持續技術進步預計將推動該領域實現良好的複合年成長率。
  • 例如，2019年7月，Oxford Nanopore推出了GridION Mk1，這是一款桌上型、靈活的NGS和資料分析儀器，可增強該公司GridION X5系統的效能。
  • 根據工作流程，資料分析步驟預計將在預測期內實現顯著的複合年成長率。
  • 引入配備 HTS-flow 的工作流程管理系統，透過從實驗室管理系統取得資料並使用簡單的 GUI 管理資料分析工作資料。
  • 這些技術已在腫瘤學領域獲得廣泛接受，用於對基因突變進行測序和編目，以開發癌症診斷和治療。
  • 全球癌症患者數量的不斷增加正在推動對腫瘤學的需求。預計2020年美國將新增近180萬名癌症病例。
  • 在預測期內，臨床研究領域預計將呈現最快的成長速度，其次是醫院和診所。
  • 公司和政府機構為擴大醫院和診斷中心對 COVID-19 診斷使用基於 NGS 的診斷測試的機會而做出的努力預計將推動醫院和診所領域以良好的速度發展。
  • 在亞太地區，由於涉及使用這些工具的眾多研究項目，預計市場在預測期內將以最高的複合年成長率發展。
  • 例如，2019年10月，科學技術研究院的研究人員創建了亞洲人口最大的遺傳資料，以幫助診斷罕見疾病。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章 DNA 定序市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/補充市場展望。
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • DNA定序市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • COVID-19感染疾病的影響分析

第4章 DNA 定序市場：產品與服務的估算與趨勢分析

  • 2023 年和 2030 年產品和服務的市場佔有率
  • 2018年至2030年市場規模、預測、趨勢分析
    • 消耗品
    • 用具
    • 服務

第5章 DNA序列市場：技術預估與趨勢分析

  • 2023年及2030年技術市場佔有率
  • 2018年至2030年市場規模、預測、趨勢分析
    • Sanger法
    • NGS
    • 第三代定序

第6章 DNA定序市場：工作流程估算與趨勢分析

  • 2023 年及 2030 年工作流程市場佔有率
  • 2018年至2030年市場規模、預測與趨勢分析
    • 前序
    • 定序
    • 資料分析

第7章 DNA序列市場：使用量估算及趨勢分析

  • 2023年及2030年應用市場佔有率
  • 2018年至2030年市場規模、預測與趨勢分析
    • 腫瘤學
    • 生殖健康
    • 臨床試驗
    • 農業基因組學/法醫學
    • HLA型檢測
    • 總體基因體學、流行病學和藥物開發
    • 消費者基因體學
    • 其他

第8章 DNA序列市場：最終用途估算與趨勢分析

  • 2023 年及 2030 年最終用途市場佔有率
  • 2018年至2030年市場規模、預測與趨勢分析

第9章 DNA序列市場：區域估算及趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 北美洲
    • 2018年至2030年北美市場預估與預測
    • 美國
    • 加拿大
  • 歐洲
    • 2018年至2030年歐洲市場估計與預測
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 2018年至2030年亞太市場估計與預測
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 2018年至2030年拉丁美洲市場估計與預測
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • MEA 市場估計/預測
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章競爭形勢

  • 公司/競爭對手分類
  • 策略規劃
  • 2023 年企業市場分析
  • 公司簡介/名單
    • Thermo Fisher Scientific, Inc
    • Agilent Technology
    • Illumina, Inc.
    • QIAGEN
    • F. Hoffmann-La Roche Ltd.
    • Oxford Nanopore Technologies plc.
    • Macrogen, Inc.
    • PerkinElmer Genomics
    • PacBio
    • BGI
    • Bio-Rad Laboratories, Inc.
    • Myriad Genetics
    • PierianDx
    • Partek Incorporated
    • Eurofins Scientific
Product Code: GVR-4-68039-070-4

DNA Sequencing Market Growth & Trends:

The global DNA sequencing market size is expected to reach USD 48.22 billion by 2030, expanding at a CAGR of 21.65% from 2024 to 2030, according to a new report by Grand View Research, Inc. The incorporation of Artificial Intelligence (AI) has increased the utility of genomic data in clinical practices and thus creates a new frontier in the advancement of genomic data analysis. In May 2020, Nvidia Corporation developed new AI tools, genomic sequencing software, and speech recognition technologies to aid the COVID-19 research efforts. Thus, AI accelerates the variant annotation and prioritization in the clinical diagnosis, which drives the market.

Since the completion of the Human Genome Project, the DNA sequencing cost has declined precipitously. The cost of decoding one person's genome was around USD 50,000 a decade ago and currently has reached nearly USD 600 in the largest genomic centers. Recently, in February 2020, BGI claimed to reduce the cost to sequence the genome to USD 100. This is expected to expand the use of this technology for prenatal tests, cancer screening, and research studies.

With a significant decrease in cost coupled with the availability of funding, several start-ups have entered the market. For instance, in January 2020, Omniome, a startup firm from the U.S., raised USD 60.0 million in Series C financing to speed up the late-stage product development and product launch of its genetic sequencing platform, which consequently fuels market progression.

DNA Sequencing Market Report Highlights:

  • Rise in the availability of services at affordable prices along with consulting services, training courses, and customer support are anticipated to drive the services segment at the fastest growth rate over the forecast period
  • Constant technological advancements in third-generation techniques with the launch of new systems are expected to drive this segment at a lucrative CAGR
  • For instance, in July 2019, Oxford Nanopore launched GridION Mk1, a benchtop, flexible NGS, data analysis device that improves the performance of the company's GridION X5 system
  • On the basis of workflow, the data analysis step is anticipated to register a considerable CAGR throughout the forecast period
  • The advent of workflow management systems with HTS-flow retrieves data from laboratory management systems and manages data analysis through a simple graphical user interface, subsequently streamlining the data analysis workflow
  • These technologies are widely accepted in the oncology field to sequence and catalog gene mutations for the development of cancer diagnostic and therapeutics
  • A rise in cancer cases globally is driving demand for oncology. It is estimated that there would be nearly 1.8 million new cancer cases in 2020 in the U.S.
  • The clinical research segment is projected to witness the fastest growth rate over the forecast period, followed by hospitals and clinics
  • Efforts undertaken by companies and government agencies to broaden the accessibility for NGS-based diagnostic tests in the hospitals and diagnostic centers for COVID-19 diagnosis is anticipated to drive the hospitals and clinics segment at a lucrative pace
  • In Asia Pacific, the market is expected to progress with the highest CAGR over the forecast period owing to numerous research programs that involve the usage of these tools
  • For instance, in October 2019, researchers from the Agency for Science, Technology and Research's Genome Institute of Singapore created the largest genetic databank of Asian populations to support the diagnosis of rare diseases

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product & Service
    • 1.2.2. Technology
    • 1.2.3. Workflow
    • 1.2.4. Application
    • 1.2.5. End-use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. DNA Sequencing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Technological advancements in sequencing techniques
      • 3.2.1.2. Rising interest in genomics research and personalized medicine
      • 3.2.1.3. Increasing applications of DNA sequencing in clinical diagnostics
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Data storage and management challenges
      • 3.2.2.2. Ethical and privacy concerns related to the use of sequencing technologies.
  • 3.3. DNA Sequencing Market Analysis Tools
    • 3.3.1. Industry analysis - Porter's
    • 3.3.2. PESTEL analysis
    • 3.3.3. COVID-19 impact analysis

Chapter 4. DNA Sequencing Market: Product & Service Estimates & Trend Analysis

  • 4.1. Product & Service Market Share, 2023 & 2030
  • 4.2. Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Following
    • 4.2.1. Consumables
      • 4.2.1.1. Consumables market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.2.2. Instruments
      • 4.2.2.1. Instruments market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.2.3. Services
      • 4.2.3.1. Services market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. DNA Sequencing Market: Technology Estimates & Trend Analysis

  • 5.1. Technology Market Share, 2023 & 2030
  • 5.2. Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Following
    • 5.2.1. Sanger sequencing
      • 5.2.1.1. Sanger sequencing market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.2.2. Next-generation sequencing (NGS)
      • 5.2.2.1. Next-generation sequencing (NGS) market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.2.2.2. Whole genome sequencing (WGS)
      • 5.2.2.2.1. Whole genome sequencing (WGS) market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.2.2.3. Whole exome sequencing (WES)
      • 5.2.2.3.1. Whole exome sequencing (WES) market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.2.2.4. Targeted sequencing & resequencing
      • 5.2.2.4.1. Targeted sequencing & resequencing market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.2.3. Third generation dna sequencing
      • 5.2.3.1. Third generation dna sequencing market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.2.3.2. Single-molecule real-time sequencing (SMRT)
      • 5.2.3.2.1. Single-molecule real-time sequencing (SMRT) market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.2.3.3. Nanopore sequencing
      • 5.2.3.3.1. Nanopore sequencing market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. DNA Sequencing Market: Workflow Estimates & Trend Analysis

  • 6.1. Workflow Market Share, 2023 & 2030
  • 6.2. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.2.1. Pre-sequencing
      • 6.2.1.1. Pre-sequencing market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.2.2. Sequencing
      • 6.2.2.1. Sequencing Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.2.3. Data Analysis
      • 6.2.3.1. Data analysis Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. DNA Sequencing Market: Application Estimates & Trend Analysis

  • 7.1. Application Market Share, 2023 & 2030
  • 7.2. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.2.1. Oncology
      • 7.2.1.1. Oncology Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.2.2. Reproductive Health
      • 7.2.2.1. Reproductive health market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.2.3. Clinical Investigation
      • 7.2.3.1. Clinical investigation Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.2.4. Agrigenomics & Forensics
      • 7.2.4.1. Agrigenomics & forensics market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.2.5. HLA Typing/Immune System Monitoring
      • 7.2.5.1. HLA Typing/Immune System Monitoring market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.2.6. Metagenomics, Epidemiology, & Drug Development
      • 7.2.6.1. Metagenomics, epidemiology, & drug development market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.2.7. Consumer Genomics
      • 7.2.7.1. Consumer genomics market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.2.8. Others
      • 7.2.8.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. DNA Sequencing Market: End-use Estimates & Trend Analysis

  • 8.1. End-use Market Share, 2023 & 2030
  • 8.2. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 8.2.1. Academic Research
      • 8.2.1.1. Academic research market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.2.2. Clinical Research
      • 8.2.2.1. Clinical research market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.2.3. Hospitals & Clinics
      • 8.2.3.1. Hospitals & clinics market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.2.4. Pharmaceutical & Biotechnology Companies
      • 8.2.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.2.5. Others
      • 8.2.5.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. DNA Sequencing Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Market Share Analysis, 2023 & 2030
  • 9.2. North America
    • 9.2.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.2.2. U.S.
      • 9.2.2.1. Key country dynamics
      • 9.2.2.2. Regulatory framework
      • 9.2.2.3. Target disease prevalence
      • 9.2.2.4. Competitive scenario
      • 9.2.2.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.2.3. Canada
      • 9.2.3.1. Key country dynamics
      • 9.2.3.2. Regulatory framework
      • 9.2.3.3. Target disease prevalence
      • 9.2.3.4. Competitive scenario
      • 9.2.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.3. Europe
    • 9.3.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.3.2. UK
      • 9.3.2.1. Key country dynamics
      • 9.3.2.2. Regulatory framework
      • 9.3.2.3. Target disease prevalence
      • 9.3.2.4. Competitive scenario
      • 9.3.2.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.3.3. Germany
      • 9.3.3.1. Key country dynamics
      • 9.3.3.2. Regulatory framework
      • 9.3.3.3. Target disease prevalence
      • 9.3.3.4. Competitive scenario
      • 9.3.3.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.3.4. France
      • 9.3.4.1. Key country dynamics
      • 9.3.4.2. Regulatory framework
      • 9.3.4.3. Target disease prevalence
      • 9.3.4.4. Competitive scenario
      • 9.3.4.5. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.3.5. Italy
      • 9.3.5.1. Key country dynamics
      • 9.3.5.2. Regulatory framework
      • 9.3.5.3. Target disease prevalence
      • 9.3.5.4. Competitive scenario
      • 9.3.5.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.3.6. Spain
      • 9.3.6.1. Key country dynamics
      • 9.3.6.2. Regulatory framework
      • 9.3.6.3. Target disease prevalence k
      • 9.3.6.4. Competitive scenario
      • 9.3.6.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.3.7. Norway
      • 9.3.7.1. Key country dynamics
      • 9.3.7.2. Regulatory framework
      • 9.3.7.3. Target disease prevalence
      • 9.3.7.4. Competitive scenario
      • 9.3.7.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.3.8. Sweden
      • 9.3.8.1. Key country dynamics
      • 9.3.8.2. Regulatory framework
      • 9.3.8.3. Target disease prevalence
      • 9.3.8.4. Competitive scenario
      • 9.3.8.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.3.9. Denmark
      • 9.3.9.1. Key country dynamics
      • 9.3.9.2. Regulatory framework
      • 9.3.9.3. Target disease prevalence
      • 9.3.9.4. Competitive scenario
      • 9.3.9.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.2. Japan
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. Regulatory framework
      • 9.4.2.3. Target disease prevalence
      • 9.4.2.4. Competitive scenario
      • 9.4.2.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.3. China
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. Regulatory framework
      • 9.4.3.3. Target disease prevalence
      • 9.4.3.4. Competitive scenario
      • 9.4.3.5. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.4. India
      • 9.4.4.1. Key country dynamics
      • 9.4.4.2. Regulatory framework
      • 9.4.4.3. Target disease prevalence
      • 9.4.4.4. Competitive scenario
      • 9.4.4.5. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.5. Australia
      • 9.4.5.1. Key country dynamics
      • 9.4.5.2. Regulatory framework
      • 9.4.5.3. Target disease prevalence
      • 9.4.5.4. Competitive scenario
      • 9.4.5.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.6. South Korea
      • 9.4.6.1. Key country dynamics
      • 9.4.6.2. Regulatory framework
      • 9.4.6.3. Target disease prevalence
      • 9.4.6.4. Competitive scenario
      • 9.4.6.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.7. Thailand
      • 9.4.7.1. Key country dynamics
      • 9.4.7.2. Regulatory framework
      • 9.4.7.3. Target disease prevalence
      • 9.4.7.4. Competitive scenario
      • 9.4.7.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5. Latin America
    • 9.5.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.2. Brazil
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Regulatory framework
      • 9.5.2.3. Target disease prevalence
      • 9.5.2.4. Competitive scenario
      • 9.5.2.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.3. Mexico
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Regulatory framework
      • 9.5.3.3. Target disease prevalence
      • 9.5.3.4. Competitive scenario
      • 9.5.3.5. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.4. Argentina
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. Regulatory framework
      • 9.5.4.3. Target disease prevalence
      • 9.5.4.4. Competitive scenario
      • 9.5.4.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6. MEA
    • 9.6.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.2. South Africa
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Regulatory framework
      • 9.6.2.3. Competitive scenario
      • 9.6.2.4. Target disease prevalence
      • 9.6.2.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.3. Saudi Arabia
      • 9.6.3.1. Key country dynamics
      • 9.6.3.2. Regulatory framework
      • 9.6.3.3. Competitive scenario
      • 9.6.3.4. Target disease prevalence
      • 9.6.3.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.4. UAE
      • 9.6.4.1. Key country dynamics
      • 9.6.4.2. Regulatory framework
      • 9.6.4.3. Target disease prevalence
      • 9.6.4.4. Competitive scenario
      • 9.6.4.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.5. Kuwait
      • 9.6.5.1. Key country dynamics
      • 9.6.5.2. Regulatory framework
      • 9.6.5.3. Competitive scenario
      • 9.6.5.4. Target disease prevalence
      • 9.6.5.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company/Competition Categorization
  • 10.2. Strategy Mapping
  • 10.3. Company Market Position Analysis, 2023
  • 10.4. Company Profiles/Listing
    • 10.4.1. Thermo Fisher Scientific, Inc
      • 10.4.1.1. Company overview
      • 10.4.1.2. Financial performance
      • 10.4.1.3. Product & service benchmarking
      • 10.4.1.4. Strategic initiatives
    • 10.4.2. Agilent Technology
      • 10.4.2.1. Company overview
      • 10.4.2.2. Financial performance
      • 10.4.2.3. Product & service benchmarking
      • 10.4.2.4. Strategic initiatives
    • 10.4.3. Illumina, Inc.
      • 10.4.3.1. Company overview
      • 10.4.3.2. Financial performance
      • 10.4.3.3. Product & service benchmarking
      • 10.4.3.4. Strategic initiatives
    • 10.4.4. QIAGEN
      • 10.4.4.1. Company overview
      • 10.4.4.2. Financial performance
      • 10.4.4.3. Product & service benchmarking
      • 10.4.4.4. Strategic initiatives
    • 10.4.5. F. Hoffmann-La Roche Ltd.
      • 10.4.5.1. Company overview
      • 10.4.5.2. Financial performance
      • 10.4.5.3. Product & service benchmarking
      • 10.4.5.4. Strategic initiatives
    • 10.4.6. Oxford Nanopore Technologies plc.
      • 10.4.6.1. Company overview
      • 10.4.6.2. Financial performance
      • 10.4.6.3. Product & service benchmarking
      • 10.4.6.4. Strategic initiatives
    • 10.4.7. Macrogen, Inc.
      • 10.4.7.1. Company overview
      • 10.4.7.2. Financial performance
      • 10.4.7.3. Product & service benchmarking
      • 10.4.7.4. Strategic initiatives
    • 10.4.8. PerkinElmer Genomics
      • 10.4.8.1. Company overview
      • 10.4.8.2. Financial performance
      • 10.4.8.3. Product & service benchmarking
      • 10.4.8.4. Strategic initiatives
    • 10.4.9. PacBio
      • 10.4.9.1. Company overview
      • 10.4.9.2. Financial performance
      • 10.4.9.3. Product & service benchmarking
      • 10.4.9.4. Strategic initiatives
    • 10.4.10. BGI
      • 10.4.10.1. Company overview
      • 10.4.10.2. Financial performance
      • 10.4.10.3. Product & service benchmarking
      • 10.4.10.4. Strategic initiatives
    • 10.4.11. Bio-Rad Laboratories, Inc.
      • 10.4.11.1. Company overview
      • 10.4.11.2. Financial performance
      • 10.4.11.3. Product & service benchmarking
      • 10.4.11.4. Strategic initiatives
    • 10.4.12. Myriad Genetics
      • 10.4.12.1. Company overview
      • 10.4.12.2. Financial performance
      • 10.4.12.3. Product & service benchmarking
      • 10.4.12.4. Strategic initiatives
    • 10.4.13. PierianDx
      • 10.4.13.1. Company overview
      • 10.4.13.2. Financial performance
      • 10.4.13.3. Product & service benchmarking
      • 10.4.13.4. Strategic initiatives
    • 10.4.14. Partek Incorporated
      • 10.4.14.1. Company overview
      • 10.4.14.2. Financial performance
      • 10.4.14.3. Product & service benchmarking
      • 10.4.14.4. Strategic initiatives
    • 10.4.15. Eurofins Scientific
      • 10.4.15.1. Company overview
      • 10.4.15.2. Financial performance
      • 10.4.15.3. Product & service benchmarking
      • 10.4.15.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global DNA sequencing market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 4 Global DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 5 Global DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 6 Global DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 7 Global DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 8 North America DNA sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 9 North America DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 10 North America DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 11 North America DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 12 North America DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 13 North America DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 U.S. DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 15 U.S. DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 16 U.S. DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 17 U.S. DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 18 U.S. DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 Canada DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 20 Canada DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 21 Canada DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 22 Canada DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 23 Canada DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Europe DNA sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 25 Europe DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 26 Europe DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Europe DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 28 Europe DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 U.S. DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 30 Germany DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 31 Germany DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 32 Germany DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 33 Germany DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Germany DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 35 UK DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 36 UK DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 37 UK DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 38 UK DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 UK DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 40 France DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 41 France DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 42 France DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 43 France DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 France DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 45 Italy DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 46 Italy DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 47 Italy DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 48 Italy DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Italy DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 50 Spain DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 51 Spain DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 52 Spain DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 53 Spain DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 Spain DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 55 Denmark DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 56 Denmark DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 57 Denmark DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 58 Denmark DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 Denmark DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 60 Sweden DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 61 Sweden DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 62 Sweden DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 63 Sweden DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 64 Sweden DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 65 Norway DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 66 Norway DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 67 Norway DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 68 Norway DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Norway DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 70 Asia Pacific DNA sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 71 Asia Pacific DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 72 Asia Pacific DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 73 Asia Pacific DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 74 Asia Pacific DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 Asia Pacific DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 76 China DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 77 China DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 78 China DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 79 China DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 80 China DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 81 Japan DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 82 Japan DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 83 Japan DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 84 Japan DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 85 Japan DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 86 India DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 87 India DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 88 India DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 89 India DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 90 India DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 91 South Korea DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 92 South Korea DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 93 South Korea DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 94 South Korea DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 95 South Korea DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 96 Australia DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 97 Australia DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 98 Australia DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 99 Australia DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 100 Australia DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 101 Thailand DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 102 Thailand DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 103 Thailand DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 104 Thailand DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 105 Thailand DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 106 Latin America DNA sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 107 Latin America DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 108 Latin America DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 109 Latin America DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 110 Latin America DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 111 Latin America DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 112 Brazil DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 113 Brazil DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 114 Brazil DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 115 Brazil DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 116 Brazil DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 117 Mexico DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 118 Mexico DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 119 Mexico DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 120 Mexico DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 121 Mexico DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 122 Argentina DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 123 Argentina DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 124 Argentina DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 125 Argentina DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 126 Argentina DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 127 MEA DNA sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 128 MEA DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 129 MEA DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 130 MEA DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 131 MEA DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 132 MEA DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 133 South Africa DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 134 South Africa DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 135 South Africa DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 136 South Africa DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 137 South Africa DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 138 Saudi Arabia DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 143 UAE DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 144 UAE DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 145 UAE DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 146 UAE DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 147 UAE DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 148 Kuwait DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 149 Kuwait DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 150 Kuwait DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 151 Kuwait DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 152 Kuwait DNA sequencing market, by workflow, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 DNA sequencing market: market outlook
  • Fig. 9 DNA sequencing segment snapshot
  • Fig. 10 DNA sequencing competitive insights
  • Fig. 11 Parent market outlook
  • Fig. 12 DNA sequencing market driver impact
  • Fig. 13 DNA sequencing market restraint impact
  • Fig. 14 DNA sequencing market: Product & service outlook and key takeaways
  • Fig. 15 DNA sequencing market: Product & service movement analysis
  • Fig. 16 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 DNA sequencing market: technology outlook and key takeaways
  • Fig. 20 DNA sequencing market: technology movement analysis
  • Fig. 21 Sanger sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Next-Generation sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Whole Genome Sequencing (WGS) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Whole Exome Sequencing (WES) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Targeted sequencing & resequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Third generation sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Single-Molecule Real-Time Sequencing (SMRT) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Nanopore sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 DNA sequencing market: workflow outlook and key takeaways
  • Fig. 30 DNA sequencing market: workflow movement analysis
  • Fig. 31 Pre-sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Data analysis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 DNA sequencing market: application outlook and key takeaways
  • Fig. 35 DNA sequencing market: application movement analysis
  • Fig. 36 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Reproductive health market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Clinical investigation market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 39 Agrigenomics & forensics market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 40 HLA typing/immune system monitoring market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Metagenomics, epidemiology & drug development market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Consumer genomics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 DNA sequencing market: end-use outlook and key takeaways
  • Fig. 45 DNA sequencing market: end-use movement analysis
  • Fig. 46 Academic research market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Clinical research market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Hospitals & Clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Pharmaceutical & biotechnology companies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Other users market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Global DNA sequencing market: Regional movement analysis
  • Fig. 52 Global DNA sequencing market: Regional outlook and key takeaways
  • Fig. 53 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 UK market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 73 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Middle East and Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 79 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)